List of works - Thibaut Pelat

Antibodies against Anthrax: Mechanisms of Action and Clinical Applications ⬇️

scientific article published on November 16, 2011

Antibodies for biodefense

scientific article

Detection of antiranibizumab antibodies among patients with exudative age-related macular degeneration

scientific article published on 20 May 2014

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

scientific article

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin

scientific article published on 9 May 2016

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

scientific article published on 18 September 2015

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

scientific article published on 09 January 2014

Effect of formulation on the stability and aerosol performance of a nebulized antibody

scientific article published on 30 October 2014

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation

scientific article

Human-like antibodies neutralizing Western equine encephalitis virus

scientific article

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

scientific article (publication date: 13 August 2009)

Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.

scientific article

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

scientific article

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

scientific article

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin

scientific article

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain

scientific article published on 17 September 2015

Obtention and engineering of non-human primate (NHP) antibodies for therapeutics.

scientific article

Structural differences of amyloid-β fibrils revealed by antibodies from phage display

scientific article published on 18 June 2015

[Recombinant antibodies for medical protection against bioterrorism agents: the example of anthrax]

scientific article published on 08 April 2010

List of works by Thibaut Pelat

Antibodies against Anthrax: Mechanisms of Action and Clinical Applications ⬇️

Antibodies for biodefense

Detection of antiranibizumab antibodies among patients with exudative age-related macular degeneration

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

Effect of formulation on the stability and aerosol performance of a nebulized antibody

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation

Human-like antibodies neutralizing Western equine encephalitis virus

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain

Obtention and engineering of non-human primate (NHP) antibodies for therapeutics.

Structural differences of amyloid-β fibrils revealed by antibodies from phage display

[Recombinant antibodies for medical protection against bioterrorism agents: the example of anthrax]